Sector: MedicalMICROMET INC (NASDAQ: MITI)
Headlines
- Micromet to Present at The Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
Nov 12, 2009 03:01 PM | MITI
- Micromet, Inc. Replay of Third Quarter 2009 Financial Results Conference Call Now Available
Nov 05, 2009 11:38 AM | MITI
- Micromet, Inc. Reports Third Quarter 2009 Financial Results
Nov 05, 2009 07:03 AM | MITI, SNY
- Micromet Buys Out MedImmune's Remaining Rights to Blinatumomab
Nov 05, 2009 06:32 AM | MITI
- Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody
Oct 29, 2009 07:01 AM | MITI, NYX, SNY
- Micromet, Inc. to Host Conference Call and Webcast to Report Third Quarter 2009 Financial Results on November 5, 2009
Oct 23, 2009 04:37 PM | MITI
- Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
Oct 21, 2009 10:30 AM | MITI
- Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
Sep 22, 2009 07:02 AM | MITI
- /C O R R E C T I O N -- Micromet, Inc./
Sep 21, 2009 10:27 AM | MITI
- Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO/ESMO on September 22, 2009
Sep 17, 2009 03:03 PM | MITI
- Qwest, McDonald's, DuPont, Palm are big movers
Jun 08, 2009 06:24 PM | DAL, GIS, MCD, MITI, PALM, Q
- Daily Record News Briefs: March 13, 2009
Mar 13, 2009 01:53 AM | AMED, EBS, ENMD, GNVC, MED, MITI
- Micromet Posts Loss, Regains Rights to Blinatumomab
Mar 12, 2009 07:37 AM | MITI
- Micromet, Inc. Reports Second Quarter 2009 Financial Results
Aug 06, 2009 07:01 AM | MITI
- Micromet Closes $80.5 Million Public Offering of Common Stock
Aug 04, 2009 10:48 AM | MITI
- Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
Aug 03, 2009 09:06 AM | MITI
- Micromet Announces Pricing of Public Offering of Common Stock
Jul 30, 2009 09:16 AM | MITI
- Micromet Announces Public Offering of Common Stock
Jul 29, 2009 04:01 PM | MITI
- Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009
Jul 27, 2009 07:02 AM | MITI
- Micromet Added to Russell 3000 Index
Jun 29, 2009 12:08 PM | MITI
- Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
Jun 18, 2009 07:01 AM | MITI
- Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
Jun 08, 2009 07:02 AM | MITI
- Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients
Jun 08, 2009 07:02 AM | MITI
- Form 4 MICROMET, INC. For: Aug 29 Filed by: PHILLIPS BARCLAY A (10K)
Nov 12, 2009 04:43 PM
- Form 3 MICROMET, INC. For: Nov 01 Filed by: Fagerberg Jan (10K)
Nov 12, 2009 10:29 AM
- Form 4 Stampacchia Otello For: Sep 28 (10K)
Sep 30, 2009 07:44 PM
- Form 4 Stampacchia Otello For: Sep 23 (10K)
Sep 25, 2009 07:12 PM
- Form 4 Stampacchia Otello For: Sep 18 (10K)
Sep 22, 2009 07:25 PM
- Form 4 Stampacchia Otello For: Sep 15 (10K)
Sep 17, 2009 06:41 PM
- Form 4 Stampacchia Otello For: Sep 10 (10K)
Sep 14, 2009 07:09 PM
- Form 4 Stampacchia Otello For: Sep 04 (10K)
Sep 09, 2009 06:44 PM
- Form 4 Stampacchia Otello For: Sep 02 (10K)
Sep 04, 2009 06:51 PM
- Form 4 Stampacchia Otello For: Aug 26 (10K)
Aug 28, 2009 05:27 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MITI
|
Compare to S&P
|
| YTD |
48.17 %
|
22.39 %
|
| 4 Weeks |
9.31 %
|
8.73 %
|
| 12 Weeks |
0.94 %
|
-5.28 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -46.67 %
|
|
EPS Growth in Last Year: -46.67 %
|
|
Sales Growth in Last Quarter: -18.44 %
|
|
Sales Growth in Last Quarter: -42.87 %
|
|
